{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T09:18:44Z","timestamp":1648804724020},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2007,10,28]],"date-time":"2007-10-28T00:00:00Z","timestamp":1193529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s00108-007-1960-4","type":"journal-article","created":{"date-parts":[[2007,10,26]],"date-time":"2007-10-26T07:23:58Z","timestamp":1193383438000},"page":"1376-1381","source":"Crossref","is-referenced-by-count":0,"title":["Medikamenteninduzierte St\u00f6rung der Nierenfunktion"],"prefix":"10.1007","volume":"48","author":[{"given":"B.K.","family":"Kr\u00e4mer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Banas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Banas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,28]]},"reference":[{"key":"1960_CR1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/archinte.165.10.1087","volume":"165","author":"Bagshaw","year":"2005","unstructured":"Bagshaw SM, Ghali WA (2005) Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Arch Intern Med 165: 1087\u20131093","journal-title":"Arch Intern Med"},{"key":"1960_CR2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archinte.166.2.161","volume":"166","author":"Bagshaw","year":"2006","unstructured":"Bagshaw SM, McAlister FA, Manns BJ, Ghali WA (2006) Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med 166: 161\u2013166","journal-title":"Arch Intern Med"},{"key":"1960_CR3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ndt\/gfg464","volume":"19","author":"Baker","year":"2004","unstructured":"Baker RJ, Pusey CD (2004) The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant 19: 8\u201311","journal-title":"Nephrol Dial Transplant"},{"key":"1960_CR4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJMcp050801","volume":"354","author":"Barrett","year":"2006","unstructured":"Barrett BJ, Parfrey PS (2006) Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 354: 379\u2013386","journal-title":"N Engl J Med"},{"key":"1960_CR5","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","volume":"8","author":"Bellomo","year":"2004","unstructured":"Bellomo R, Ronco C, Kellum JA et al. (2004) Acute renal failure \u2013 definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: R204\u2013R212","journal-title":"Crit Care"},{"key":"1960_CR6","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/ndt\/14.5.1146","volume":"14","author":"Erley","year":"1999","unstructured":"Erley CM, Duda SH, Rehfuss D et al. (1999) Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant 14: 1146\u20131149","journal-title":"Nephrol Dial Transplant"},{"key":"1960_CR7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ncpneph0346","volume":"3","author":"Kr\u00e4mer","year":"2007","unstructured":"Kr\u00e4mer BK, Hoffmann U (2007) Benefit of acetylcysteine for prevention of contrast-induced nephropathy after primary angioplasty. Nat Clin Pract Nephrol 3: 10\u201311","journal-title":"Nat Clin Pract Nephrol"},{"key":"1960_CR8","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1093\/ndt\/14.12.2830","volume":"14","author":"Kr\u00e4mer","year":"1999","unstructured":"Kr\u00e4mer BK, Kammerl M, Schweda F, Schreiber M (1999) A primer in radiocontrast-induced nephropathy. Nephrol Dial Transplant 14: 2830\u20132834","journal-title":"Nephrol Dial Transplant"},{"key":"1960_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000075811","volume":"27","author":"Kr\u00e4mer","year":"2004","unstructured":"Kr\u00e4mer BK, Kammerl MC, K\u00f6mhoff M (2004) Renal cyclooxygenase-2 (COX-2) Physiological, pathophysiological, and clinical implications. Kidney Blood Press Res 27: 43\u201362","journal-title":"Kidney Blood Press Res"},{"key":"1960_CR10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(05)17831-3","volume":"365","author":"Lameire","year":"2005","unstructured":"Lameire N, Van Biesen W, Vanholder R (2005) Acute renal failure. Lancet 365: 417\u2013430","journal-title":"Lancet"},{"key":"1960_CR11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ki.1996.380","volume":"50","author":"Liano","year":"1996","unstructured":"Liano F, Pascual J (1996) Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 50: 811\u2013818","journal-title":"Kidney Int"},{"key":"1960_CR12","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1523-1755.2004.00927.x","volume":"66","author":"Mehta","year":"2004","unstructured":"Mehta RL, Pascual MT, Soroko S et al. (2004) Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int 66: 1613\u20131621","journal-title":"Kidney Int"},{"key":"1960_CR13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM200007203430304","volume":"343","author":"Tepel","year":"2000","unstructured":"Tepel M, Giet M van der, Schwarzfeld C et al. (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343: 180\u2013184","journal-title":"N Engl J Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1960-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-007-1960-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1960-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:12:06Z","timestamp":1558584726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-007-1960-4"}},"subtitle":["Was ist zu beachten?"],"short-title":[],"issued":{"date-parts":[[2007,10,28]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["1960"],"URL":"https:\/\/doi.org\/10.1007\/s00108-007-1960-4","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,28]]}}}